Cardiology
Conference Coverage
Alpha-blockers deemed safe in heart failure
WASHINGTON – Plus a bonus: Improved heart failure outcomes
Conference Coverage
New-onset AF boosts bad HFrEF outcomes
WASHINGTON – Monitor patients with heart failure with reduced ejection fraction for atrial fibrillation.
Conference Coverage
Gliflozins’ heart failure protection in type 2 diabetes confirmed
WASHINGTON – Cardioprotection appears to be a class effect of SGLT-2 inhibitors.
Conference Coverage
Hard road disproving that statins make you dumb
Do statins adversely affect mental health? The short answer is “no.”
Conference Coverage
Refractory vasovagal syncope responds to DDD-CLS pacing
SPAIN trial provides effective new therapy.
Commentary
Is auscultation really better than echocardiography?
Is auscultation really better thanechocardiography? In a recent letter to the editor on the role of auscultation and echocardiography, “Point-of-...
Clinical Inquiries
Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP?
EVIDENCE-BASED ANSWER: Yes for angiotensin-converting enzyme (ACE) inhibitors, no for angiotensin receptor blockers (ARBs).
Conference Coverage
Choice of protease inhibitor may impact CVD risk in HIV+ patients
Older protease inhibitors had been shown to be associated with increased CVD risk, but the newer generation of drugs had not been similarly...
Conference Coverage
Statins may protect against HIV rebound
Statins appeared to reduce the risk of viral rebound in HIV patients on antiretroviral therapy, suggesting modest antiviral activity.
Conference Coverage
‘Sobering’ high 10-year mortality post-MI after age 65
The CRUSADE community practice registry shows median survival of only 4.8 years.
Conference Coverage
Marijuana abuse linked to increased MI risk
WASHINGTON – Association between pot and MI booms in young adults.